ORAGENICS, INC. Discontinued Operation, Tax Effect of Discontinued Operation
ORAGENICS, INC. (OGEN) reported Discontinued Operation, Tax Effect of Discontinued Operation of $0 for the 12-month period ending 2017-12-31, per its 10-K filed 2018-02-16.
Discontinued › Expense Statement › Operating Expenses
us-gaap:DiscontinuedOperationTaxEffectOfDiscontinuedOperation · last filed 2018-02-16
- ORAGENICS, INC. discontinued operation, tax effect of discontinued operation for the quarter ending 2017-12-31 was $0.00.
- ORAGENICS, INC. discontinued operation, tax effect of discontinued operation for the quarter ending 2017-09-30 was $0.00.
- ORAGENICS, INC. discontinued operation, tax effect of discontinued operation for the quarter ending 2017-06-30 was $0.00.
- ORAGENICS, INC. discontinued operation, tax effect of discontinued operation for the quarter ending 2017-03-31 was $0.00.
- ORAGENICS, INC. discontinued operation, tax effect of discontinued operation for fiscal 2017 was $0.00.
- ORAGENICS, INC. discontinued operation, tax effect of discontinued operation for fiscal 2016 was $0.00.
- ORAGENICS, INC. discontinued operation, tax effect of discontinued operation for fiscal 2015 was $0.00.
| Period end | Discontinued Operation, Tax Effect of Discontinued Operation 3 month | Discontinued Operation, Tax Effect of Discontinued Operation 6 month | Discontinued Operation, Tax Effect of Discontinued Operation 9 month | Discontinued Operation, Tax Effect of Discontinued Operation 12 month |
|---|---|---|---|---|
| 2017-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-16 | $0.00 derived: sum of 2 quarters · filed 2018-02-16 | $0.00 derived: sum of 3 quarters · filed 2018-02-16 | $0.00 10-K · filed 2018-02-16 |
| 2017-09-30 | $0.00 10-Q · filed 2017-10-31 | $0.00 derived: sum of 2 quarters · filed 2017-10-31 | $0.00 10-Q · filed 2017-10-31 | $0.00 derived: sum of 4 quarters · filed 2018-02-16 |
| 2017-06-30 | $0.00 10-Q · filed 2017-08-14 | $0.00 10-Q · filed 2017-08-14 | $0.00 derived: sum of 3 quarters · filed 2018-02-16 | $0.00 derived: sum of 4 quarters · filed 2018-02-16 |
| 2017-03-31 | $0.00 10-Q · filed 2017-05-15 | $0.00 derived: sum of 2 quarters · filed 2018-02-16 | $0.00 derived: sum of 3 quarters · filed 2018-02-16 | $0.00 derived: sum of 4 quarters · filed 2018-02-16 |
| 2016-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-16 | $0.00 derived: sum of 2 quarters · filed 2018-02-16 | $0.00 derived: sum of 3 quarters · filed 2018-02-16 | $0.00 10-K · filed 2018-02-16 |
| 2016-09-30 | $0.00 10-Q · filed 2017-10-31 | $0.00 derived: sum of 2 quarters · filed 2017-10-31 | $0.00 10-Q · filed 2017-10-31 | $0.00 derived: sum of 4 quarters · filed 2017-10-31 |
| 2016-06-30 | $0.00 10-Q · filed 2017-08-14 | $0.00 10-Q · filed 2017-08-14 | $0.00 derived: sum of 3 quarters · filed 2017-08-14 | $0.00 derived: sum of 4 quarters · filed 2017-08-14 |
| 2016-03-31 | $0.00 10-Q · filed 2017-05-15 | $0.00 derived: sum of 2 quarters · filed 2017-05-15 | $0.00 derived: sum of 3 quarters · filed 2017-05-15 | $0.00 derived: sum of 4 quarters · filed 2017-05-15 |
| 2015-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-27 | $0.00 derived: sum of 2 quarters · filed 2017-02-27 | $0.00 derived: sum of 3 quarters · filed 2017-02-27 | $0.00 10-K · filed 2017-02-27 |
| 2015-09-30 | $0.00 10-Q · filed 2016-11-14 | $0.00 derived: sum of 2 quarters · filed 2016-11-14 | $0.00 10-Q · filed 2016-11-14 | |
| 2015-06-30 | $0.00 10-Q · filed 2016-08-15 | $0.00 10-Q · filed 2016-08-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| Nexentis Technologies Inc. (NXTS) | $0.002B | ||
| Decoy Therapeutics Inc. (DCOY) | United States | $0.002B | -0.27 |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |